PRECIPIO, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
PRECIPIO, INC. (PRPO) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $2.18 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2022-03-30
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-06-30 was $1.82M, a 56.03% decline year-over-year.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-03-31 was $353.00K, a 88.71% decline year-over-year.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2020 was $2.18M, a 71.19% decline from fiscal 2019.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2019 was $7.55M, a 220.59% increase from fiscal 2018.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2018 was $2.36M, a 50.62% decline from fiscal 2017.
- PRECIPIO, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2017 was $4.77M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 6 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 9 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $1.82M derived: sum of 3 quarters · filed 2022-03-30 | $2.18M 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.82M derived: sum of 2 quarters · filed 2021-11-12 | $2.18M 10-Q · filed 2021-11-12 | $2.34M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.82M 10-Q · filed 2021-08-12 | $2.18M 10-Q · filed 2021-08-12 | $2.34M derived: sum of 3 quarters · filed 2021-08-12 | $2.46M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $353.00K 10-Q · filed 2021-05-14 | $516.00K derived: sum of 2 quarters · filed 2021-05-14 | $634.00K derived: sum of 3 quarters · filed 2021-05-14 | $4.78M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $281.00K derived: sum of 2 quarters · filed 2021-03-29 | $4.43M derived: sum of 3 quarters · filed 2021-03-29 | $7.55M 10-K · filed 2021-03-29 |
| 2019-09-30 | $118.00K 10-Q · filed 2020-11-13 | $4.26M derived: sum of 2 quarters · filed 2020-11-13 | $7.39M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $4.15M 10-Q · filed 2020-08-13 | $7.27M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $3.13M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $2.36M 10-K · filed 2020-03-27 | |||
| 2017-12-31 | $4.77M 10-K · filed 2019-04-16 | |||
| 2015-12-31 | $1.17M 10-K · filed 2017-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |